Characterization of vitamin D receptor immunoreactivity in human bone cells

Bone

Volumn 27, Issue 3, 2000, Pages 383-387

  Langub, M C ^a   Reinhardt, T A ^b   Horst, R L ^b   Malluche, H H ^a   Koszewski, N J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Antiserum; Bone; Calcitriol; Immunohistochemical; Osteoclasts; VDR

Indexed keywords

VITAMIN D RECEPTOR;

ARTICLE; BONE CELL; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NORMAL HUMAN; OSTEOCLAST; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BASE SEQUENCE; BONE AND BONES; CELL LINE; CELL NUCLEUS; DNA PRIMERS; GOATS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PEPTIDE FRAGMENTS; RATS; RECEPTORS, CALCITRIOL;

EID: 0033837976     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00335-5     Document Type: Article

References (20)

1. Bellido T., Girasole G., Passeri G., Yu X.P., Mocharla H., Jilka R.L., Notides A., Manolagas S.C. Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3 . Endocrinology. 133:1993;553-562.
2. Berger U., Wilson P., McClelland R.A., Colston K., Haussler M.R., Pike J.W., Coombes R.C. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 67:1988;607-613.
3. Boivin G., Mesguich P., Pike J.W., Bouillon R., Meunier P.J., Haussler M.R., Dubois P.M., Morel G. Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. Bone Miner. 3:1987;125-136.
4. Clemens T.L., Garrett K.P., Zhou X.Y., Pike J.W., Haussler M.R., Dempster D.W. Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology. 122:1988;1224-1230.
5. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor biological and molecular regulatory properties revealed . J Bone Miner Res. 13:1998;325-349.
6. Horwood N.J., Elliott J., Martin T.J., Gillespie M.T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 139:1998;4743-4746.
7. Johnson J.A., Grande J.P., Roche P.C., Kumar R. Ontogeny of the 1,25-dihydroxyvitamin D3 receptor in fetal rat bone. J Bone Miner Res. 11:1996;56-61.
8. Koszewski N.J., Reinhardt T.A., Horst R.L. Differential effects of 20-epi vitamin D analogs on the vitamin D receptor homodimer. J Bone Miner Res. 14:1999;509-517.
9. Koszewski N.J., Reinhardt T.A., Langub M.C., Malluche H.H., Horst R.L. Selectivity of a C-terminal peptide antiserum for different DNA-binding states of the vitamin D receptor. Arch Biochem Biophys. 349:1998;388-396.
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
11. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., et al. The nuclear receptor superfamily the second decade . Cell. 83:1995;835-839.
12. Mee A.P., Hoyland J.A., Braidman I.P., Freemont A.J., Davies M., Mawer E.B. Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections. Bone. 18:1996;295-299.
13. Menaa C., Barsony J., Reddy S.V., Cornish J., Cundy T., Roodman G.D. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease. J Bone Miner Res. 15:2000;228-236.
14. Merke J., Klaus G., Hugel U., Waldherr R., Ritz E. No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium- deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest. 77:1986;312-314.
15. Reichrath J., Collins E.D., Epple S., Kerber A., Norman A.W., Bahmer F.A. Immunohistochemical detection of 1,25-dihydroxyvitamin D3 receptors (VDR) in human skin. Path Res Pract. 192:1996;281-289.
16. Sandgren M.E., Bronnegard M., DeLuca H.F. Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun. 181:1991;611-661.
17. Stumpf W.E., Koike N., Hayakawa N., Tokuda K., Nishimiya K., Tsuchiya Y., Hirate J., Okazaki A., Kumaki K. 1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification. Histochemistry. 102:1994;183-194.
18. Suda T., Udagawa N., Nakamura I., Miyaura C., Takahashi N. Modulation of osteoclast differentiation by local factors. Bone. 17:(2 Suppl):1995;87-91.
19. Takeda S., Yoshizawa T., Nagai Y., Yamato H., Fukumoto S., Sekine K., Kato S., Matsumoto T., Fujita T. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells studies using VDR knockout mice . Endocrinology. 140:1999;1005-1008.
20. Tuohimaa P., Blauer M., Jaaskelainen T., Itkonen A., Lindfors M., Mahonen A., Palvimo J., Vilja P., Maenpaa P.H. Characterization of human 1,25-dihydroxyvitamin D3 receptor anti-peptide antibodies. J Steroid Biochem Mol Biol. 43:1992;649-657.